» Articles » PMID: 18314518

Ablation Therapy Guided by Contrast-enhanced Sonography with Sonazoid for Hepatocellular Carcinoma Lesions Not Detected by Conventional Sonography

Overview
Date 2008 Mar 4
PMID 18314518
Citations 32
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: We evaluated the usefulness of contrast-enhanced harmonic gray scale sonography with a newly developed sonographic contrast medium as a means of guidance for percutaneous ablation therapy of hepatocellular carcinoma lesions not detected by conventional sonography.

Methods: We examined 85 patients with 108 hepatocellular carcinoma lesions that were identified as hypervascular by multidetector-row computed tomography by using contrast-enhanced harmonic gray scale sonography after injection of Sonazoid (GE Healthcare, Oslo, Norway), a lipid-stabilized suspension of a perfluorobutane gas microbubble contrast agent. We scanned the whole liver by this modality at a low mechanical index in the late phase to detect lesions not detected by conventional sonography and then scanned the lesions again by this modality at a high mechanical index to visualize tumor vessels and enhancement. We also performed percutaneous ablation therapy guided by this modality to treat viable hepatocellular carcinoma lesions that could not be detected by conventional sonography.

Results: Conventional sonography identified 90 (83%) of 108 hepatocellular carcinoma lesions; 15 (14%) additional viable lesions not detected by conventional sonography were detected in the late phase of contrast-enhanced harmonic gray scale sonography at a low mechanical index, and tumor vessels and enhancement were observed in the late phase at a high mechanical index. Contrast-enhanced harmonic gray scale sonography diagnosed 105 (97%) of the 108 viable hepatocellular carcinoma lesions, and 14 (93%) of the 15 lesions not detected by conventional sonography were successfully treated by percutaneous ablation therapy guided by this modality.

Conclusions: Contrast-enhanced harmonic gray scale sonography is useful for guidance of percutaneous ablation therapy of hepatocellular carcinoma lesions not detected by conventional sonography.

Citing Articles

Developments in the Use of Indocyanine Green (ICG) Fluorescence in Colorectal Surgery.

Khalafi S, Botero Fonnegra C, Reyes A, Hui V J Clin Med. 2024; 13(14).

PMID: 39064041 PMC: 11276973. DOI: 10.3390/jcm13144003.


Usefulness of Body Position Change during Local Ablation Therapies for the High-Risk Location Hepatocellular Carcinoma.

Takada H, Komiyama Y, Osawa L, Muraoka M, Suzuki Y, Sato M Cancers (Basel). 2024; 16(5).

PMID: 38473393 PMC: 10930729. DOI: 10.3390/cancers16051036.


Use of Near-Infrared Fluorescence Techniques in Minimally Invasive Surgery for Colorectal Liver Metastases.

Patel I, Rehman S, McKay S, Bartlett D, Mirza D J Clin Med. 2023; 12(17).

PMID: 37685603 PMC: 10488819. DOI: 10.3390/jcm12175536.


Contrast Agents for Hepatocellular Carcinoma Imaging: Value and Progression.

Zhang Y, Numata K, Du Y, Maeda S Front Oncol. 2022; 12:921667.

PMID: 35720001 PMC: 9200965. DOI: 10.3389/fonc.2022.921667.


Abdominal Ultrasound and Treatment of Hepatocellular Carcinoma.

Numata K Diagnostics (Basel). 2021; 11(7).

PMID: 34359352 PMC: 8303704. DOI: 10.3390/diagnostics11071268.